Autres langues West Pharmaceutical Services, Inc. Boerse Muenchen

Actions

WPS

US9553061055

Equipement, fournitures et distribution médicale

Temps réel Boerse Muenchen 15:13:35 06/10/2026			Varia. 5j.	Varia. 1 janv.
335,00 ^EUR	+0,13%		+0,74%	+44,33%

15:31	West Pharmaceutical Services, Inc. : Barclays favorable sur le dossier	ZM
23/09	Les entreprises américaines confrontées à une hausse des cyberattaques	RE

Autres langues

05/10	West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
23/09	US companies face rise in cyber attacks
22/09	West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says
15/09	West Pharmaceutical Services Insider Sold Shares Worth $2,671,260, According to a Recent SEC Filing
04/09	US companies face rise in cyber attacks
01/09	Oncology firm Novocure says cyberattack exposed US patient records
26/08	West to Participate in Upcoming Investor Conferences
26/08	Boston Scientific hit by cyberattack, global operations affected
03/08	Is everything under control?
31/07	Amgen discloses data breach involving patient health information
23/07	Tranche Update on West Pharmaceutical Services, Inc.'s Equity Buyback Plan announced on February 17, 2026.
23/07	West Pharmaceutical Services, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
23/07	West Pharma raises profit forecast on strong demand for injectable drug components
23/07	West Pharmaceutical Services, Inc. Increases Earnings Guidance for the Full Year 2026
23/07	West Pharmaceutical Services, Inc. Provides Earnings Guidance for the Third Quarter of 2026
23/07	West Pharmaceutical Services Q2 Adjusted Earnings, Net Sales Rise; 2026 Outlook Boosted
23/07	West Pharmaceutical raises annual profit forecast on strong demand for injectable drug components
23/07	(WST) West Pharmaceutical Services, Inc. Expects Q3 Revenue Range $820.0M - $835.0M
23/07	(WST) West Pharmaceutical Services Expects Full Year 2026 Adjusted EPS Range $8.85 - $9.05, vs. FactSet Est of $8.62
23/07	(WST) West Pharmaceutical Services, Inc. Expects Q3 Adjusted EPS Range $2.14 - $2.24
23/07	Earnings Flash (WST) West Pharmaceutical Services, Inc. Reports Q2 Revenue $872.3M, vs. FactSet Est of $840.0M
23/07	(WST) West Pharmaceutical Services Expects Full Year 2026 Net Sales Range $3.35B - $3.38B vs. FactSet Est of $3.33B
23/07	Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q2 Adjusted EPS $2.37 per Share, vs. FactSet Est of $2.08
23/07	West Pharmaceutical: Q2 Earnings Snapshot
23/07	West Reports Second-Quarter 2026 Results